Trigelan^®

Trigelan^® contains the three active substances levodopa, carbidopa and entacapone in one film-coated tablet.

Trigelan^® is a medicine used to treat Parkinson’s disease.

Parkinson’s is caused by a deficiency of the neurotransmitter dopamine in the brain. Levodopa increases the amount of dopamine and thus reduces the symptoms of Parkinson’s disease. Carbidopa and entacapone improve the antiparkinsonian effects of levodopa.

Trigelan^® Package Leaflet (German version), last revised 06.2020

Active substance: Levodopa, Carbidopa, Entacapone

Strength	Pack size	Dosage form	Appearance
50 mg/12,5 mg/200 mg	30, 100	Film-coated tablets
100 mg/25 mg/200 mg	30, 100	Film-coated tablets
150 mg/37,5 mg/200 mg	30, 100	Film-coated tablets
200 mg/50 mg/200 mg	30, 100	Film-coated tablets